Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy

• Main Authors: M L Maximov, O V Dralova
• Format: Article
• Language: English
• Published: Peoples’ Friendship University of Russia (RUDN University) 2010-09-01
• Series: RUDN Journal of Medicine
• Subjects: валсартан; БРА; артериальная гипертония; хроническая болезнь почек; нефропротекция
• Online Access: http://journals.rudn.ru/medicine/article/view/3545

Angiotensin II receptor blockers are highly effective and safe drugs that reduce the activity of RAAS. Valsartan is a quality, efficient antihypertensive drug with good tolerability. The effectiveness of valsartan is a combination of hemodynamic, neurohumoral, and metabolic effects, providing a positive outlook and steadfast nephroprotective. Combining a good tolerability, ease of use and lack of significant side effects, valsartan can rightly be considered the drug of first choice for treating such patients.